What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Parkinson's disease
- Disease
His scientific interests lie mostly in Parkinson's disease, Internal medicine, Central nervous system disease, Endocrinology and Neuroscience.
A large part of his Parkinson's disease studies is devoted to Levodopa.
His Internal medicine study combines topics in areas such as Pathology and Cardiology.
His Central nervous system disease research integrates issues from Resting state fMRI, Case-control study and Huntington's disease.
His Endocrinology research includes themes of Fluorodeoxyglucose and Positron emission tomography.
His biological study spans a wide range of topics, including Rating scale, Psychiatry and Intensive care medicine.
His most cited work include:
- The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease (852 citations)
- Valvular heart disease and the use of dopamine agonists for Parkinson's disease. (699 citations)
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria (612 citations)
What are the main themes of his work throughout his whole career to date?
Angelo Antonini mainly focuses on Parkinson's disease, Internal medicine, Disease, Levodopa and Neurology.
The Parkinson's disease study combines topics in areas such as Anesthesia, Dopaminergic, Physical therapy and Quality of life.
His research investigates the link between Internal medicine and topics such as Endocrinology that cross with problems in Positron emission tomography.
His Disease research incorporates elements of Physical medicine and rehabilitation, Quality of life, Psychiatry, Intensive care medicine and Pediatrics.
His Levodopa study incorporates themes from Adverse effect, Dyskinesia and Apomorphine.
The concepts of his Neurology study are interwoven with issues in Neurosurgery and Dementia.
He most often published in these fields:
- Parkinson's disease (64.32%)
- Internal medicine (29.73%)
- Disease (21.62%)
What were the highlights of his more recent work (between 2018-2021)?
- Parkinson's disease (64.32%)
- Disease (21.62%)
- Internal medicine (29.73%)
In recent papers he was focusing on the following fields of study:
Parkinson's disease, Disease, Internal medicine, Quality of life and Physical medicine and rehabilitation are his primary areas of study.
As part of his studies on Parkinson's disease, Angelo Antonini often connects relevant areas like Neurology.
His Parkinsonism study, which is part of a larger body of work in Disease, is frequently linked to Pandemic, bridging the gap between disciplines.
His Tolerability, Dopaminergic and Apathy study in the realm of Internal medicine interacts with subjects such as 2019-20 coronavirus outbreak.
His work deals with themes such as Carbidopa, Propensity score matching, Cohort and Mood, which intersect with Quality of life.
The various areas that Angelo Antonini examines in his Physical medicine and rehabilitation study include Cognition, Neuropsychology, Randomized controlled trial and Activities of daily living.
Between 2018 and 2021, his most popular works were:
- Outcome of Parkinson's Disease Patients Affected by COVID-19. (65 citations)
- EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. (45 citations)
- How to Apply the Movement Disorder Society Criteria for Diagnosis of Progressive Supranuclear Palsy (40 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Parkinson's disease
Angelo Antonini mostly deals with Parkinson's disease, Internal medicine, Disease, Quality of life and Dyskinesia.
Angelo Antonini has researched Parkinson's disease in several fields, including Dementia, Physical medicine and rehabilitation and Mood.
His Internal medicine study frequently links to adjacent areas such as Depression.
Angelo Antonini has included themes like Virus, Immunology, Clinical trial and Intensive care medicine in his Disease study.
His work in Dyskinesia addresses subjects such as Levodopa carbidopa, which are connected to disciplines such as Non motor, Drug reaction and Gastroenterology.
His research integrates issues of Neurology and Amantadine in his study of Deep brain stimulation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
